Five takeaways from POLITICO’s ‘How Fast Can We Solve Alzheimer’s’ Event

Key Facts

• | Rod Lamkey Jr. for POLITICO Senior lawmakers and health policy experts said Wednesday that the United States is well-positioned to move forward on new diagnostics and treatments for Alzheimer’s disease — poised to build on new technologies.
• Guthrie, the House Energy and Commerce Health Subcommittee chair, said he plans to soon hold a hearing that includes the reauthorization of the BOLD Act.
• “First things first, let’s get diagnostics and treatments that really work,” Kaine said, adding that he doesn’t want to see the agency reduce its quality standards for drugs being reviewed under its accelerated approval pathway.
• George Vradenburg, chairman and co-founder of UsAgainstAlzheimer’s, said that the decision by drugmaker Biogen to discontinue development and marketing for Aduhelm, a controversial Alzheimer’s disease treatment, reflects the consequences of Medicare’s coverage decisions.

Click To Read Full Article